Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process

Authors: Dogan, Izzet, Kizildag, Inci, Özkurt, Selnur, Ibis, Kamuran, Vatansever, Sezai, Saip, Pinar, Aydiner, Adnan

Source: Oncology. 101(4):262-269

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179027330.0x000001&indx=1&recIds=ETOCvdc_100179027330.0x000001

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

Authors: Özdemir, Özlem, Zengel, Baha, Yildiz, Yaşar, Uluç, Basak Oyan, Cabuk, Devrim, Ozden, Ercan, Salim, Derya Kivrak, Paydas, Semra, Demir, Atakan, Diker, Omer, Pilanci, Kezban Nur, Sönmez, Özlem Uysal, Vatansever, Sezai, Dogan, Izzet, Gulmez, Ahmet, Cakar, Burcu, Gursoy, Pinar, Yildirim, Mahmut Emre, Ayhan, Murat, Karadurmus, Nuri, Aykan, Musa Baris, Cevik, Gökcen Tugba, Sakalar, Teoman, Hacibekiroglu, Ilhan, Gülbagci, Burcu Belen, Dincer, Murat, Garbioglu, Duygu Bayir, Kemal, Yasemin, Nayir, Erdinc, Taskaynatan, Halil, Yilmaz, Mesut, Avci, Okan, Sari, Murat, Coban, Ezgi, Atci, Muhammed Mustafa, Esen, Selin Aktürk, Telli, Tugba Akin, Karatas, Fatih, Inal, Ali, Demir, Hacer, Kalkan, Nurhan Onal, Yilmaz, Cengiz, Tasli, Funda, Alacacioglu, Ahmet

Source: Anti-cancer drugs. 33(7):663-670

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167377061.0x000001&indx=1&recIds=ETOCvdc_100167377061.0x000001

Dramatic response to single‐agent atezolizumab in a patient with MSI‐H serous ovarian cancer

Authors: Ak, Naziye, Vatansever, Sezai

Source: Journal of clinical pharmacy and therapeutics. 46(6):1787-1791

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100134601705.0x000001&indx=1&recIds=ETOCvdc_100134601705.0x000001

Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients.

Authors: Erciyestepe, Mert, Selvi, Oğuzhan, Dinç, Gülhan, Öztürk, Ahmet Emin, Aydın, Okan, Dinç Sonuşen, Şermin, Güneş, Tuğçe Kübra, Avcı, Tugay, Vatansever, Sezai, Çelik, Emir, Atcı, Muhammed Mustafa

Source: Oncology; 2024, Vol. 102 Issue 12, p1009-1017, 9p

Subject Terms: RISK assessment, CANCER relapse, RETROSPECTIVE studies, DESCRIPTIVE statistics, CHI-squared test, MANN Whitney U Test, COLON tumors, ADJUVANT chemotherapy, KAPLAN-Meier estimator, TUMOR classification, SURVIVAL analysis (Biometry), PROGRESSION-free survival, DATA analysis software, PROPORTIONAL hazards models, DISEASE risk factors

Efficacy of Intrathecal Therapy In Breast Cancer Patients With Leptomeningeal Metastasis.

Authors: Khanmammadov, Nijat, Dogan, Izzet, Ahmed, Melin Aydan, Yildiz, Anil, Nizam, Nihan, Khishigsuren, Bayarmaa, Azizy, Abdulmunir, Vatansever, Sezai, Saip, Pınar, Aydiner, Adnan

Source: Eastern Journal of Medicine; Oct-Dec2024, Vol. 29 Issue 4, p503-508, 6p

Subject Terms: HER2 positive breast cancer, METASTATIC breast cancer, SPINAL infusions, OVERALL survival, PROGRESSION-free survival, LOBULAR carcinoma

'Door to Treatment' Outcomes of Cancer Patients during the COVID-19 Pandemic

Authors: Ak, Naziye, Vatansever, Sezai

Source: Chemotherapy. 65(5/6):141-146

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116009270.0x000001&indx=1&recIds=ETOCvdc_100116009270.0x000001

Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1.

Authors: Dogan, Izzet, Ahmed, Melin Aydan, Yıldız, Anıl, Vatansever, Sezai

Source: Indian Journal of Surgical Oncology; Sep2024, Vol. 15 Issue 3, p484-488, 5p

Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients.

Authors: Dogan, Izzet, Yıldız, Anıl, Ahmed, Melin Aydan, Vatansever, Sezai

Source: Indian Journal of Surgical Oncology; Sep2024, Vol. 15 Issue 3, p489-494, 6p

The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer

Authors: Avsar, Mukaddes, Tambas, Makbule, Yalniz, Zubeyde, Akdeniz, Demet, Tuncer, Seref Bugra, Kilic, Seda, Sukruoglu Erdogan, Ozge, Ciftci, Rumeysa, Dagoglu, Nergiz, Vatansever, Sezai, Yazici, Hulya

Source: MOLECULAR BIOLOGY REPORTS. 46(4):4001-4008

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100118594896.0x000001&indx=1&recIds=ETOCvdc_100118594896.0x000001

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Authors: Ciftci, Rumeysa, Tas, Faruk, Bilgin, Elif, Keskin, Serkan, Yildiz, Ibrahim, Duranyildiz, Derya, Saip, Pınar, Karanlik, Hasan, Vatansever, Sezai

Source: In Journal of Oncological Science April 2016 2(1):7-11

Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer.

Authors: Erciyestepe, Mert, Selvi, Oğuzhan, Dinç Sonuşen, Şermin, Öztürk, Ahmet Emin, Dinç, Gülhan, Güneş, Tuğçe Kübra, Aydın, Okan, Yaşar, Nurgül, Balkaya Aykut, Gözde, Vatansever, Sezai

Source: Medical Principles & Practice; 2024, Vol. 33 Issue 2, p122-132, 11p

Subject Terms: NON-small-cell lung carcinoma, PROGNOSIS, PLATELET lymphocyte ratio, NEUTROPHIL lymphocyte ratio, OVERALL survival

Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST.

Authors: Yirgin, Inci Kizildag, Dogan, Izzet, Engin, Gulgun, Vatansever, Sezai, Erturk, Sukru Mehmet

Source: Journal of Cancer Research & Therapeutics; Jan-Mar2024, Vol. 20, p156-162, 7p

Subject Terms: IMMUNE checkpoint inhibitors, COHEN'S kappa coefficient (Statistics), LOG-rank test, IPILIMUMAB, OVERALL survival, DISEASE progression

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data

Authors: Gürbüz, Mustafa, Doğan, İzzet, Akkuş, Erman, Ermiş, Hande, Utkan, Güngör, Vatansever, Sezai, Taş, Faruk

Source: Dermatologic therapy. 34(6)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139897740.0x000001&indx=1&recIds=ETOCvdc_100139897740.0x000001

Physical therapy in cancer related vs non-cancer trismus

Authors: Diraçoğlu, Demirhan, Şen, Ekin İlke, Vatansever, Sezai, Çapan, Nalan, Karan, Ayşe

Source: Stomatologija. 18(4):107-111

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN614002589&indx=1&recIds=ETOCRN614002589

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.

Authors: Dogan, Izzet, Iribas, Ayca, Paksoy, Nail, Vatansever, Sezai, Basaran, Mert

Source: Journal of Cancer Research & Therapeutics; 2023 Suppl 2, Vol. 19, p587-591, 5p

Subject Terms: BRAIN metastasis, PROGNOSIS, RENAL cell carcinoma, SIZE of brain, PROTEIN-tyrosine kinase inhibitors, METASTASIS

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors.

Authors: Dogan, Izzet, Khanmammadov, Nijat, Yıldız, Anıl, Ahmed, Melin, Vatansever, Sezai, Saip, Pinar, Aydiner, Adnan

Source: Journal of Cancer Research & Therapeutics; Oct-Dec2023, Vol. 19 Issue 7, p1945-1949, 5p

Subject Terms: PROTEIN-tyrosine kinase inhibitors, NON-small-cell lung carcinoma, EPIDERMAL growth factor receptors, CANCER patients, LOGISTIC regression analysis

The Significance of Preoperative Computed Tomography Features in the Prediction of Overall Survival in Gastric Cancer: A Retrospective Analysis.

Authors: Yirgin, Inci Kizildag, Dogan, Izzet, Vatansever, Sezai, Erturk, Sukru Mehmet

Source: Medical Bulletin of Sisli Etfal Hospital; 2023, Vol. 57 Issue 2, p195-203, 9p

Subject Terms: COMPUTED tomography, OVERALL survival, STOMACH cancer, MULTIVARIATE analysis, POSTOPERATIVE care, SURGICAL excision, UNIVARIATE analysis

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.

Authors: Doğan, İzzet, Paksoy, Nail, Ak, Naziye, Vatansever, Sezai, Saip, Pınar, Aydıner, Adnan

Source: European Journal of Breast Health; Apr2023, Vol. 19 Issue 2, p128-133, 6p

Subject Terms: PROGRESSION-free survival, BREAST cancer treatment, BREAST surgery, BREAST care, LAPATINIB

Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC

Authors: Dogan, Izzet, Gurbuz, Mustafa, Paksoy, Nail, Ferhatoglu, Ferhat, Vatansever, Sezai, Saip, Pinar, Demirkazik, Ahmet, Aydiner, Adnan

Source: Medicine. 101(34):e30188-e30188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178305282.0x000001&indx=1&recIds=ETOCvdc_100178305282.0x000001

Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma

Authors: Sen, Fatma, Tambas, Makbule, Ciftci, Rumeysa, Toz, Bahtiyar, Kilic, Leyla, Bozbey, Hamza U., Karanlik, Hasan, Kurul, Sidika, Vatansever, Sezai, Oral, Ethem N., Saglam, Esra K., Kizir, Ahmet, Saip, Pinar, Aydiner, Adnan

Source: Journal of dermatological treatment. 27(3):275-277

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100105242260.0x000001&indx=1&recIds=ETOCvdc_100105242260.0x000001